TipRanks
Chong Kun Dang Pharmaceutical Corp. (KR:185750)
:185750
South Korea Market
185750
Chong Kun Dang Pharmaceutical Corp.
RESEARCH TOOLSreports

Chong Kun Dang Pharmaceutical Corp. (185750) Ratios

1 Followers

Chong Kun Dang Pharmaceutical Corp. Ratios

KR:185750's free cash flow for Q2 2026 was ₩0.29. For the 2026 fiscal year, KR:185750's free cash flow was decreased by ₩ and operating cash flow was ₩0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.04 2.12 2.61 1.85 1.91
Quick Ratio
 1.25 1.28 1.65 1.34 1.19
Cash Ratio
 0.36 0.42 0.62 0.43 0.31
Solvency Ratio
 0.15 0.15 0.26 0.43 0.23
Operating Cash Flow Ratio
 0.23 0.13 0.17 0.62 0.18
Short-Term Operating Cash Flow Coverage
 0.79 0.41 0.97 1.75 0.55
Net Current Asset Value
₩ 230.14B₩ 297.88B₩ 399.77B₩ 359.78B₩ 210.02B
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.20 0.13 0.16 0.21
Debt-to-Equity Ratio
 0.43 0.37 0.21 0.27 0.38
Debt-to-Capital Ratio
 0.30 0.27 0.17 0.21 0.27
Long-Term Debt-to-Capital Ratio
 0.21 0.16 0.11 0.04 0.15
Financial Leverage Ratio
 1.84 1.79 1.63 1.72 1.81
Debt Service Coverage Ratio
 0.77 0.72 2.13 1.36 0.92
Interest Coverage Ratio
 9.74 12.03 11.96 26.60 16.05
Debt to Market Cap
 0.50 0.33 0.15 0.14 0.26
Interest Debt Per Share
 32.27K 28.42K 14.83K 18.00K 19.80K
Net Debt to EBITDA
 1.98 1.21 -0.27 <0.01 0.86
Profitability Margins
Gross Profit Margin
29.03%30.56%33.57%39.67%36.46%
EBIT Margin
4.39%4.76%6.95%15.02%6.99%
EBITDA Margin
6.95%7.41%9.46%17.23%9.24%
Operating Profit Margin
4.33%4.76%6.27%14.77%7.38%
Pretax Profit Margin
4.31%4.82%6.43%14.47%6.53%
Net Profit Margin
4.46%4.60%6.88%12.73%5.44%
Continuous Operations Profit Margin
4.46%4.60%7.02%12.80%5.37%
Net Income Per EBT
103.40%95.31%106.92%87.96%83.32%
EBT Per EBIT
99.59%101.35%102.56%97.97%88.41%
Return on Assets (ROA)
4.26%4.32%7.48%15.15%7.20%
Return on Equity (ROE)
7.97%7.75%12.20%26.05%13.01%
Return on Capital Employed (ROCE)
5.77%6.27%9.12%27.68%14.64%
Return on Invested Capital (ROIC)
5.16%5.30%8.58%20.27%10.34%
Return on Tangible Assets
4.59%4.60%7.89%15.74%7.37%
Earnings Yield
8.83%7.13%9.25%13.63%8.88%
Efficiency Ratios
Receivables Turnover
 5.65 5.62 5.29 5.36 5.30
Payables Turnover
 6.51 5.52 5.27 5.48 6.50
Inventory Turnover
 3.02 2.74 2.98 3.85 3.50
Fixed Asset Turnover
 4.10 3.87 4.95 5.22 4.79
Asset Turnover
 0.96 0.94 1.09 1.19 1.32
Working Capital Turnover Ratio
 3.32 2.89 3.08 4.31 4.34
Cash Conversion Cycle
 129.22 131.99 122.28 96.18 117.00
Days of Sales Outstanding
 64.65 64.98 69.05 68.10 68.90
Days of Inventory Outstanding
 120.66 133.14 122.55 94.74 104.24
Days of Payables Outstanding
 56.10 66.12 69.32 66.66 56.13
Operating Cycle
 185.32 198.11 191.60 162.84 173.13
Cash Flow Ratios
Operating Cash Flow Per Share
 8.93K 5.11K 4.85K 25.01K 5.53K
Free Cash Flow Per Share
 -5.01K -5.58K -136.89 19.60K 1.20K
CapEx Per Share
 13.94K 10.69K 4.99K 5.41K 4.33K
Free Cash Flow to Operating Cash Flow
 -0.56 -1.09 -0.03 0.78 0.22
Dividend Paid and CapEx Coverage Ratio
 0.62 0.44 0.81 3.96 1.05
Capital Expenditure Coverage Ratio
 0.64 0.48 0.97 4.62 1.28
Operating Cash Flow Coverage Ratio
 0.28 0.18 0.34 1.45 0.29
Operating Cash Flow to Sales Ratio
 0.07 0.04 0.04 0.19 0.05
Free Cash Flow Yield
-8.06%-6.73%-0.15%15.99%1.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.81 14.09 10.85 7.34 11.27
Price-to-Sales (P/S) Ratio
 0.48 0.65 0.74 0.93 0.61
Price-to-Book (P/B) Ratio
 0.89 1.09 1.32 1.91 1.47
Price-to-Free Cash Flow (P/FCF) Ratio
 -12.41 -14.86 -650.16 6.25 62.18
Price-to-Operating Cash Flow Ratio
 7.30 16.21 18.34 4.90 13.47
Price-to-Earnings Growth (PEG) Ratio
 0.35 -0.50 -0.21 0.05 0.10
Price-to-Fair Value
 0.89 1.09 1.32 1.91 1.47
Enterprise Value Multiple
 8.91 9.92 7.59 5.42 7.49
Enterprise Value
 1.10T 1.24T 1.14T 1.56T 1.03T
EV to EBITDA
 8.91 9.92 7.59 5.42 7.49
EV to Sales
 0.62 0.73 0.72 0.93 0.69
EV to Free Cash Flow
 -15.95 -16.92 -627.93 6.25 70.24
EV to Operating Cash Flow
 8.96 18.46 17.71 4.90 15.21
Tangible Book Value Per Share
 63.90K 68.22K 61.96K 59.98K 48.52K
Shareholders’ Equity Per Share
 73.57K 76.19K 67.49K 64.11K 50.81K
Tax and Other Ratios
Effective Tax Rate
 -0.04 0.05 -0.09 0.12 0.18
Revenue Per Share
 129.16K 128.46K 119.77K 131.21K 121.51K
Net Income Per Share
 5.76K 5.91K 8.23K 16.70K 6.61K
Tax Burden
 1.03 0.95 1.07 0.88 0.83
Interest Burden
 0.98 1.01 0.92 0.96 0.93
Research & Development to Revenue
 0.06 0.09 0.09 0.08 0.12
SG&A to Revenue
 0.06 0.08 0.09 0.08 0.08
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.55 0.87 0.58 1.49 0.85
Currency in KRW